Jae Young Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jae Young Oh has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Hee-Myung Park
Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University
4 shared publications - Jong-Chan Chae
Division of Biotechnology, Jeonbuk National University, Iksan 54596, Republic of Korea
3 shared publications Chang-Bum Ahn
Department of Food Technology and Nutrition, Chonnam National University, Yeosu, Republic of Korea
2 shared publicationsEui Jeong Han
Department of Food Technology and Nutrition, Chonnam National University, Yeosu, Republic of Korea
2 shared publications- Ginnae Ahn
Department of Food Technology and Nutrition Chonnam National University Yeosu Republic of Korea
2 shared publications - Jae Hong Jeong
Division of Biotechnology, Jeonbuk National University, Iksan 54596, Korea
2 shared publications
Latest Publications
- Open Access
- 9 August 2026
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 50, 522-527
Transferable IncX3-blaKPC-2 plasmid and chromosomal blaCTX−M-27 in a commensal Escherichia coli ST7854 isolated from a healthy companion dog
- 9 August 2026
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 50, 522-527
Open AccessTransferable IncX3-blaKPC-2 plasmid and chromosomal blaCTX−M-27 in a commensal Escherichia coli ST7854 isolated from a healthy companion dog
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Veterinary Science
- Vol. 26 (1) , e14
Molecular characterization of uropathogenic Escherichia coli (UPEC) strains isolated from companion dogs and cats in Korea
Oh JY, et al. J Vet Sci. 2025 Jan;26:e14. https://doi.org/10.4142/jvs.24244
- 1 January 2025
- Published by XMLink in Journal of Veterinary Science
- Vol. 26 (1) , e14
Open AccessMolecular characterization of uropathogenic Escherichia coli (UPEC) strains isolated from companion dogs and cats in Korea
Oh JY, et al. J Vet Sci. 2025 Jan;26:e14. https://doi.org/10.4142/jvs.24244
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Veterinary Science
- Vol. 26 (1)
Whole genome sequencing analysis of enteropathogenic Escherichia coli from human and companion animals in Korea
Oh JY, et al. J Vet Sci. 2024 Dec;26:e1. https://doi.org/10.4142/jvs.24225
- 1 January 2025
- Published by XMLink in Journal of Veterinary Science
- Vol. 26 (1)
Open AccessWhole genome sequencing analysis of enteropathogenic Escherichia coli from human and companion animals in Korea
Oh JY, et al. J Vet Sci. 2024 Dec;26:e1. https://doi.org/10.4142/jvs.24225
- Open Access
- 25 January 2024
- Published by Korean Society of Animal Science and Technology in Journal of Animal Science and Technology
- Vol. 67 (5) , 1181-1184
Complete genome of blaCTX-M-65-carrying Salmonella Infantis strain Z01323CSL0015 isolated from broiler chicken
Journal of Animal Science and Technology (JAST) is a peer-reviewed, open access journal publishing original research, review articles and notes in all fields of animal science. Topics covered by the journal include: genetics and breeding, physiology, nutrition of monogastric animals, nutrition of ruminants, animal products (milk, meat, eggs and their by-products) and their processing, grasslands and roughages, livestock environment, animal biotechnology, animal behavior and welfare.
- 25 January 2024
- Published by Korean Society of Animal Science and Technology in Journal of Animal Science and Technology
- Vol. 67 (5) , 1181-1184
Open AccessComplete genome of blaCTX-M-65-carrying Salmonella Infantis strain Z01323CSL0015 isolated from broiler chicken
Journal of Animal Science and Technology (JAST) is a peer-reviewed, open access journal publishing original research, review articles and notes in all fields of animal science. Topics covered by the journal include: genetics and breeding, physiology, nutrition of monogastric animals, nutrition of ruminants, animal products (milk, meat, eggs and their by-products) and their processing, grasslands and roughages, livestock environment, animal biotechnology, animal behavior and welfare.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Veterinary Science
- Vol. 22 (2) , e17
Prevalence and antimicrobial resistance of Klebsiella species isolated from clinically ill companion animals
Lee D, et al. J Vet Sci. 2021 Mar;22(2):e17. https://doi.org/10.4142/jvs.2021.22.e17
- 1 January 2021
- Published by XMLink in Journal of Veterinary Science
- Vol. 22 (2) , e17
Open AccessPrevalence and antimicrobial resistance of Klebsiella species isolated from clinically ill companion animals
Lee D, et al. J Vet Sci. 2021 Mar;22(2):e17. https://doi.org/10.4142/jvs.2021.22.e17
- Open Access
- 15 April 2020
- Published by Springer Nature in BMC Veterinary Research
- Vol. 16 (1) , 1-8
Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs
Background: Fluoroquinolone agents, such as enrofloxacin and marbofloxacin, are commonly used for pseudomonal infection in veterinary medicine. However, the rate of resistance to fluoroquinolones is rapidly increasing, according to multiple studies in various countries. Point mutations in the quinolone resistance-determining region (QRDR) are closely related to the increased fluoroquinolone resistance of Pseudomonas aeruginosa. The aim of this study was to investigate current antimicrobial susceptibility and fluoroquinolone resistance in P. aeruginosa strains isolated from dogs. The presence of point mutations in the QRDR was confirmed by gyrA and parC polymerase chain reaction and nucleotide sequencing analysis. Results: A total of 84 nonduplicated P. aeruginosa strains were obtained from 228 healthy dogs (healthy group) and 260 dogs with clinical signs (infected group). Among these isolates, 38 strains from the healthy group were detected in several sample types, whereas 46 strains from the infected group were obtained mostly from dogs’ ears with otitis externa (41/260, 15.8%). All strains were resistant to nalidixic acid, while some were also resistant to enrofloxacin (23/84, 27.4%), marbofloxacin (17/84, 20.2%), levofloxacin (12/84, 14.3%), or ciprofloxacin (11/84, 13.1%). Enrofloxacin resistance was significantly higher in strains from the infected group than in those from the healthy group (p < 0.05). Among the 23 fluoroquinolone-resistant strains, 8 and 4 different mutations were detected in the gyrA and parC genes, respectively. Mutations in gyrA were significantly common in the infected group (p < 0.05). Hotspots for the gyrA and parC mutations were Thr83 (34.8%, 8/23) and Pro116 (91.3%, 21/23), respectively. Double and triple mutations were also found in 5 of the strains. Conclusion: Novel mutations in the gyrA and parC genes were first found in P. aeruginosa isolated from companion dogs in South Korea. These findings suggest that it is important to encourage prudent use of fluoroquinolone antibiotics in canine pseudomonal infection treatment.
- 15 April 2020
- Published by Springer Nature in BMC Veterinary Research
- Vol. 16 (1) , 1-8
Open AccessAntimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs
Background: Fluoroquinolone agents, such as enrofloxacin and marbofloxacin, are commonly used for pseudomonal infection in veterinary medicine. However, the rate of resistance to fluoroquinolones is rapidly increasing, according to multiple studies in various countries. Point mutations in the quinolone resistance-determining region (QRDR) are closely related to the increased fluoroquinolone resistance of Pseudomonas aeruginosa. The aim of this study was to investigate current antimicrobial susceptibility and fluoroquinolone resistance in P. aeruginosa strains isolated from dogs. The presence of point mutations in the QRDR was confirmed by gyrA and parC polymerase chain reaction and nucleotide sequencing analysis. Results: A total of 84 nonduplicated P. aeruginosa strains were obtained from 228 healthy dogs (healthy group) and 260 dogs with clinical signs (infected group). Among these isolates, 38 strains from the healthy group were detected in several sample types, whereas 46 strains from the infected group were obtained mostly from dogs’ ears with otitis externa (41/260, 15.8%). All strains were resistant to nalidixic acid, while some were also resistant to enrofloxacin (23/84, 27.4%), marbofloxacin (17/84, 20.2%), levofloxacin (12/84, 14.3%), or ciprofloxacin (11/84, 13.1%). Enrofloxacin resistance was significantly higher in strains from the infected group than in those from the healthy group (p < 0.05). Among the 23 fluoroquinolone-resistant strains, 8 and 4 different mutations were detected in the gyrA and parC genes, respectively. Mutations in gyrA were significantly common in the infected group (p < 0.05). Hotspots for the gyrA and parC mutations were Thr83 (34.8%, 8/23) and Pro116 (91.3%, 21/23), respectively. Double and triple mutations were also found in 5 of the strains. Conclusion: Novel mutations in the gyrA and parC genes were first found in P. aeruginosa isolated from companion dogs in South Korea. These findings suggest that it is important to encourage prudent use of fluoroquinolone antibiotics in canine pseudomonal infection treatment.
- Open Access
- 1 January 2020
- Published by XMLink in Journal of Veterinary Science
- Vol. 21 (3) , e40
High-level mupirocin resistance in Gram-positive bacteria isolated from diseased companion animals
Sum S, et al. J Vet Sci. 2019 Oct;21:e40. https://doi.org/10.4142/jvs.2020.21.e40
- 1 January 2020
- Published by XMLink in Journal of Veterinary Science
- Vol. 21 (3) , e40
Open AccessHigh-level mupirocin resistance in Gram-positive bacteria isolated from diseased companion animals
Sum S, et al. J Vet Sci. 2019 Oct;21:e40. https://doi.org/10.4142/jvs.2020.21.e40
- 1 January 2017
- Published by Springer Nature
- Vol. 975, 643-653
Protective Effects of Xylose-Taurine Reduced against Damages Caused by Oxidative Stress in Zebrafish Embryos In Vivo Model
The zebrafish (Danio rerio) is useful and convenient vertebrate models in various studies in human disease and drug discovery. In this present study, we first evaluated whether Xylose-Taurine reduced (X-T-R), a taurine derivate protects zebrafish embryos against oxidative stress caused by AAPH (2,2′-Azobis(2-amidinopropane) dihydrochloride). First of all, we selected the concentration of X-T-R showing no toxicity in zebrafish embryos. We identified that X-T-R significantly increased the survival of zebrafish embryo reduced by treatment of AAPH. Also, X-T-R effectively inhibited the productions of reactive oxygen species (ROS) and nitric oxide (NO) as well as the formation of cell death in zebrafish embryos. Moreover, X-T-R down-regulated the expression levels of Bax, caspase-3, caspase-9 and p53 known as pro-apoptotic molecules, whereas up-regulated those of Bcl-2, an anti-apoptotic molecule in AAPH-treated zebrafish embryos. From these results, this study reveals that X-T-R, a taurine derivate might be a potential protector against various damages caused by oxidative stress.
- 1 January 2017
- Published by Springer Nature
- Vol. 975, 643-653
Protective Effects of Xylose-Taurine Reduced against Damages Caused by Oxidative Stress in Zebrafish Embryos In Vivo Model
The zebrafish (Danio rerio) is useful and convenient vertebrate models in various studies in human disease and drug discovery. In this present study, we first evaluated whether Xylose-Taurine reduced (X-T-R), a taurine derivate protects zebrafish embryos against oxidative stress caused by AAPH (2,2′-Azobis(2-amidinopropane) dihydrochloride). First of all, we selected the concentration of X-T-R showing no toxicity in zebrafish embryos. We identified that X-T-R significantly increased the survival of zebrafish embryo reduced by treatment of AAPH. Also, X-T-R effectively inhibited the productions of reactive oxygen species (ROS) and nitric oxide (NO) as well as the formation of cell death in zebrafish embryos. Moreover, X-T-R down-regulated the expression levels of Bax, caspase-3, caspase-9 and p53 known as pro-apoptotic molecules, whereas up-regulated those of Bcl-2, an anti-apoptotic molecule in AAPH-treated zebrafish embryos. From these results, this study reveals that X-T-R, a taurine derivate might be a potential protector against various damages caused by oxidative stress.
- 1 January 2017
- Published by Springer Nature
- Vol. 975, 943-953
Anti-inflammatory Effects of Galactose-Taurine Sodium Salt in LPS-Activated RAW 264.7 Cells
In this study, we synthesized Galactose-Taurine sodium salt (G-T) as a functional food ingredient to enhance biological activities of taurine. Also, anti-inflammatory effects of G-T were investigated in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. G-T found to reduce the generations of the LPS-stimulated nitric oxide (NO) and prostaglandin E2 (PGE2) via down-regulating the expression levels of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2). Also, G-T reduced the secretion of inflammatory cytokines including interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF-α) in LPS-treated RAW 264.7 cells. Finally, we identified that G-T inhibits the activation of nuclear factor-κB (NF-κB) and the phosphorylation of inhibitor κB (IκB)-α. From these results, this study first suggests that G-T could be considered as an effective anti-inflammatory agent.
- 1 January 2017
- Published by Springer Nature
- Vol. 975, 943-953
Anti-inflammatory Effects of Galactose-Taurine Sodium Salt in LPS-Activated RAW 264.7 Cells
In this study, we synthesized Galactose-Taurine sodium salt (G-T) as a functional food ingredient to enhance biological activities of taurine. Also, anti-inflammatory effects of G-T were investigated in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. G-T found to reduce the generations of the LPS-stimulated nitric oxide (NO) and prostaglandin E2 (PGE2) via down-regulating the expression levels of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2). Also, G-T reduced the secretion of inflammatory cytokines including interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF-α) in LPS-treated RAW 264.7 cells. Finally, we identified that G-T inhibits the activation of nuclear factor-κB (NF-κB) and the phosphorylation of inhibitor κB (IκB)-α. From these results, this study first suggests that G-T could be considered as an effective anti-inflammatory agent.